Allianz Asset Management
PBYI icon

Allianz Asset Management’s Puma Biotechnology PBYI Stock Holding History

Allianz Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,392
Closed -$434K – 2715
2017
Q4 		$434K Buy
4,392
+1,049
+31% +$117K ﹤0.01% 2447
2017
Q3 		$400K Sell
3,343
-456
-12% -$42.4K ﹤0.01% 2468
2017
Q2 		$330K Buy
+3,799
New +$213K ﹤0.01% 2490
2015
Q2 		– Sell
-13,960
Closed -$3.3M – 2474
2015
Q1 		$3.3M Sell
13,960
-45,684
-77% -$9.77M ﹤0.01% 1372
2014
Q4 		$11.3M Sell
59,644
-49,387
-45% -$11M 0.01% 912
2014
Q3 		$26M Sell
109,031
-22,564
-17% -$4.63M 0.03% 544
2014
Q2 		$8.69M Buy
+131,595
New +$9.36M 0.01% 773

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return